US Patent 7901679 Humanized anti-ghrelin antibodies
Patent 7901679 was granted and assigned to Eli Lilly and Company on March, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 27 Nov, 2023
Golden AI
Edits made to:
Article (+336 characters)
Article
Patent abstract
Provided are humanized monoclonal antibodies, and antigen-binding portions thereof, which bind acylated and unacylated human ghrelin. Such antibodies are useful for neutralizing ghrelin activity and treating disorders in which ghrelin activity is detrimental, including obesity and related disorders, and various cancers.
Edits on 19 Sep, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Danise Rogers Subramaniam0
David Matthew Marquis0
Derrick Ryan Witcher0
Eric Michael Smith0
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07901679 Humanized anti-ghrelin antibodies US Patent 7901679 Humanized anti-ghrelin antibodies
Infobox
Patent Number
079016790
Patent Number
79016790
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 30 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
079016790
Date of Patent
March 8, 2011
0Patent Application Number
122784190
Date Filed
February 21, 2007
0Official Website
Patent Primary Examiner
Edits on 4 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 7 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07901679 Humanized anti-ghrelin antibodies
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07901679
Date of patent
March 8, 2011
Patent application number
12278419
Date Filed
February 21, 2007
Patent primary examiner
Find more entities like US Patent 7901679 Humanized anti-ghrelin antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
